Printer Friendly
The Free Library
19,607,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Dendreon Corporation to Participate in SG Cowen Global Health Care Conference.


Business Editors & Health/Medical Writers

BIOWIRE2K

SEATTLE--(BUSINESS WIRE)--Nov. 8, 2002

Dendreon Corporation (Nasdaq:DNDN) today announced that it will present at the SG Cowen Global Health Care Conference at The Hotel Inter-Continental in Paris at 4:55 p.m. Paris Time/7:55 a.m. Pacific Standard Time on Wednesday, Nov. 13, 2002.

Mitchell Mitchell, city (1990 pop. 13,798), seat of Davison co., SE S.Dak.; inc. 1881. Mitchell is a trade, distribution, and shipping center for a dairy and livestock area.  H. Gold, M.D., chief business officer, will make the presentation. On Oct. 30, it was announced that Gold will be promoted to chief executive officer effective Jan. 1, 2003.

Members of the public can listen to a live webcast of the presentation by visiting Dendreon's website www.dendreon.com under "News & Events" or through the SG Cowen website at www.sgcowen.com. In addition, the presentation will be available by replay for 30 days.

Dendreon Corporation is a biotechnology company developing targeted therapies for cancer. Dendreon currently has three therapeutic vaccines therapeutic vaccine Immunology A vaccine–eg, Salk's Remune intended to treat a viral infection by stimulating the immune system. See Vaccine therapy.  in clinical trials. Dendreon's product pipeline also includes monoclonal antibodies This is a list of monoclonal antibodies, antibodies which are clones of a single parent cell. When used as medications, the generic names end in -mab (see "Nomenclature of monoclonal antibodies").  and a pathway pathway /path·way/ (path´wa)
1. a course usually followed.

2. the nerve structures through which an impulse passes between groups of nerve cells or between the central nervous system and an organ or muscle.
 to small molecules. Dendreon has established important alliances with industry leaders Genentech, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., and Kirin Brewery A brewery can be a building or place that produces beer, or a business (brewing company) whose trade is the production and sale of beer. Breweries can take up multiple city blocks, or be a collection of equipment in a homebrewer's kitchen.  Co., Ltd. For more information, visit www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 that are subject to risks and uncertainties that may cause actual results to differ materially from the results discussed in the forward-looking statements, particularly those risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
. Factors that may cause such a difference include risks related to the uncertainty of Dendreon's future access to capital, Dendreon's limited operating history, risks associated with completing Dendreon's clinical trials, the risk that the safety and/or efficacy results of a clinical trial will not support an application for a biologics license, the risk that the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 will not approve a product for which a biologics license has been applied, the failure by Dendreon to secure and maintain relationships with collaborators, dependence on the efforts of third parties, and dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations, are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 8, 2002
Words:387
Previous Article:Claim Jumper Restaurant Opens in Scottsdale.
Next Article:M7 Corporation Appoints Jawahar Malhotra as Vice President of Engineering; Web Services Pioneer Adds to Company's Technical Strength.
Topics:



Related Articles
Dendreon Corporation Files Registration Statement for the Public Offering of 2,500,000 Shares of Common Stock.
Dendreon To Acquire Corvas; New Company Will Have Multiple Clinical Products, Significant Oncology R&D Pipeline, Strong Cash Position and Experienced...
Dendreon Corporation to Present at the SG Cowen Healthcare Conference.
LifePoint Hospitals to Participate in SG Cowen 23rd Annual Health Care Conference.
Dendreon Corporation Completes Acquisition of Corvas International; Creates Oncology Company with Enhanced Product Pipeline and Strong Financial...
Dendreon Corporation to Participate in the UBS Global Life Sciences Conference.
Caremark Rx to Present Jointly with AdvancePCS at The SG Cowen 24th Annual Health Care Conference.
Dendreon Corporation to Present at SG Cowen Health Care Conference.
Molina Healthcare to Participate in SG Cowen & Co. 6th Annual Global Health Care Conference.
Diomed Holdings, Inc. to Present at SG Cowen's 26th Annual Health Care Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles